Merck in deal to study generic version of Enbrel - Forbes

Genetic Engineering tidings Merck in deal to study generic version of Enbrel Forbes Merck & Co. will team ahead with a South peninsula company to study and sell a generic version of the rheumatoid arthritis and psoriasis drug Enbrel, the company said Monday. Merck did not bring out financial terms of its agreement with Hanwha natural science Corp. ... Merck and Hanwha ink deal to develop biosimilar Enbrel Proactive Investors USA & North American country Merck, South Korea's Hanwha To Co-develop Biosimilar nominee RTT News Merck & Co. Teams with Hanwha to Develop Biosimilar Enbrel Genetic Engineering News Drug Store News  - Zenopa  - The Korea messenger all 51 news articles » Link To Article